Key result
Emerging data suggests Hispanics in the U.S. may have rates of uncontrolled hypertension significantly exceeding those of non-Hispanic whites, despite ~6% of all U.S. adults remaining undiagnosed.
Highlights the critical need for better representation of Hispanics in hypertension clinical trials and improved understanding of hypertension management in this growing population.
Hypertension (HTN) is a very prevalent and growing clinical problem that is not always promptly diagnosed and ∼6% of U.S. adults remain undiagnosed. Though numerous risk factors have been linked to the development of HTN, ethnicity has traditionally been simply considered as a significant risk among non-Hispanic Blacks. However, emerging data seems to suggest that Hispanics, the largest and fastest-growing minority in the U.S.A., might have rates of uncontrolled HTN that significantly exceeds the rates observed for non-Hispanic whites. Unfortunately, paucity of a significant Hispanic representation in major clinical trials has raised significant healthcare concerns regarding our true understanding of the meaning of HTN and associated cardiovascular consequences among this ethnic group. Consequently, there is urgency not only in having a better understanding of HTN among Hispanics, but also to examine the potential factors that may play a role in regulating the expression of HTN and its associated cardiovascular manifestations in this ethnic group.
No takes yet. Share an insight, caveat, or question.
Angel López‐Candales (2015) conducted a review in Hypertension. Emerging data suggests Hispanics in the U.S. may have rates of uncontrolled hypertension significantly exceeding those of non-Hispanic whites, despite ~6% of all U.S. adults remaining undiagnosed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: